#USA #Houston #PointClickCare #AccessDx Laboratory #pharmacogenomics

AccessDx Laboratory Enhances Integration with PointClickCare

In a significant development in precision medicine, AccessDx Laboratory has announced an expanded integration with PointClickCare, a leader in healthcare technology solutions. This collaboration is set to revolutionize the way healthcare providers deliver personalized care to residents across the nation.

AccessDx Laboratory specializes in precision medicine and diagnostic solutions, aiming to enhance patient outcomes through innovative practices. The latest integration with PointClickCare focuses on seamless delivery of pharmacogenomic (PGx) risk assessments, advanced diagnostic results, and continuous PGx monitoring. With these tools at their disposal, healthcare providers can quickly identify potentially dangerous drug-gene interactions, ensuring a safer medication regimen for their patients.

Bryon Cipriani, CEO of AccessDx Laboratory, expressed his enthusiasm for this collaboration, stating, "We are pleased to announce our integration into PointClickCare's solution that helps to enable access to precision medicine solutions for long-term and post-acute care (LTPAC) providers. It signifies our shared commitment to empowering care organizations with actionable insights that significantly benefit both providers and residents."

The integration is particularly crucial for long-term and post-acute care facilities, where each patient often requires meticulous attention to medication interactions. In a recent multi-facility analysis, facilities utilizing this integration were able to identify about 77% of their residents who faced severe or moderate drug-gene interaction risks. This proactive identification process enhances patient safety and leverages real-time insights for improved care.

As residents' medication records are updated within the system, clinicians participating in AccessDx Laboratory's Risk Mitigation for Seniors Program gain access to real-time PGx insights. This means they can immediately implement modifications in treatment plans to mitigate risks associated with drug interactions, thereby providing tailored healthcare protocols that enhance residents' well-being.

This collaboration with PointClickCare represents a significant step in integrating technology with healthcare practices, making the process more efficient and effective. Mike Boesveld, Director of Marketplace Strategy at PointClickCare, also highlighted the importance of their partnership by stating, "Our Marketplace Partners provide world-class technology and share our deep commitment to ensuring our customers have access to the most powerful, efficient, and effective solutions."

AccessDx Laboratory is recognized as a CLIA-certified, CAP-accredited, and NYSDOH-approved diagnostic laboratory. Their services encompass a wide array of testing, including pharmacogenomics (PGx) testing, cancer genomic (CGX) testing, and infectious disease testing, supporting healthcare providers nationwide in delivering high-quality patient care.

With such advancements and commitments to excellence from both AccessDx Laboratory and PointClickCare, the future of precision medicine looks promising. As the healthcare landscape continues to evolve, this integration serves as a model for enhancing resident care through innovation and collaboration.

To learn more, reach out to AccessDx Laboratory’s media contact or visit their website.